Publication | Closed Access
Insulin degludec has a two-fold longer half-life and a more consistent pharmacokinetic profile compared with insulin glargine
40
Citations
0
References
2012
Year
Molecular PharmacologyDiabetes ManagementConsistent Pharmacokinetic ProfileInsulin GlargineInsulin DegludecDiabetesPharmacologyInsulin ManagementDiabetes MellitusInsulin DeliveryMedicineInsulin Signaling
No additional data available for this publication yet. Check back later!